Incidence and survival of malignant pleural mesothelioma in Norway: A population-based study of 1686 cases

Journal of Thoracic Oncology

Volumn 7, Issue 12, 2012, Pages 1858-1861

  Helland, Åslaug ^a,b   Solberg, Steinar ^c   Brustugun, Odd Terje ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Mesothelioma; Pemetrexed; Populationbased study; Prognostic factors; Survival

Indexed keywords

PEMETREXED;

ARTICLE; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NORWAY; PALLIATIVE THERAPY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 84870359722     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318275b346     Document Type: Article

References (20)

1. McDonald JC, McDonald AD. The epidemiology of mesothelioma in historical context. Eur Respir J 1996;9:1932-1942. (Pubitemid 26294767)
2. Park EK, Takahashi K, Hoshuyama T, et al. Global magnitude of reported and unreported mesothelioma. Environ Health Perspect 2011;119:514-518.
3. Driscoll T, Nelson DI, Steenland K, et al. The global burden of disease due to occupational carcinogens. Am J Ind Med 2005;48:419-431. (Pubitemid 41746860)
4. Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005;353:1591-1603. (Pubitemid 41434638)
5. Nagai H, Okazaki Y, Chew SH, et al. Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis. Proc Natl Acad Sci USA 2011;108:E1330-E1338.
6. Hodgson DC, Gilbert ES, Dores GM, et al. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol 2007;25:1489-1497. (Pubitemid 46759253)
7. Marinaccio A, Binazzi A, Cauzillo G, et al.; Italian Mesothelioma Register (ReNaM) Working Group. Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register. Eur J Cancer 2007;43:2722-2728. (Pubitemid 350161848)
8. van Meerbeeck JP, Damhuis R. Facts, rumours and speculations about the mesothelioma epidemic. Respirology 2011;16:1018-1019.
9. Milano MT, Zhang H. Malignant pleural mesothelioma: a population-based study of survival. J Thorac Oncol 2010;5:1841-1848.
10. Montanaro F, Rosato R, Gangemi M, et al. Survival of pleural malignant mesothelioma in Italy: a population-based study. Int J Cancer 2009;124:201-207.
11. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-2644. (Pubitemid 46606305)
12. Larsen IK, Småstuen M, Johannesen TB, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009;45:1218-1231.
13. Available at: http://legeforeningen.no/pagefiles/95119/ thoraxkirurgiregisteret%202010.ppt#1. Accessed June 19, 2012.
14. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982;38:933-942.
15. Ulvestad B, Kjaerheim K, Moøller B, Andersen A. Incidence trends of mesothelioma in Norway, 1965-1999. Int J Cancer 2003;107:94-98. (Pubitemid 37100091)
16. Available at: http://ibasecretariat.org/chron-ban-list.php. Accessed June 19, 2012.
17. Treasure T, Lang-Lazdunski L, Waller D, et al.; MARS trialists. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2011;12:763-772.
18. Waite K, Gilligan D. The role of radiotherapy in the treatment of malignant pleural mesothelioma. Clin Oncol (R Coll Radiol) 2007;19:182-187.
19. Fennell DA, Gaudino G, O'Byrne KJ, Mutti L, van Meerbeeck J. Advances in the systemic therapy of malignant pleural mesothelioma. Nat Clin Pract Oncol 2008;5:136-147.
20. Damhuis RA, Schroten C, Burgers JA. Population-based survival for malignant mesothelioma after introduction of novel chemotherapy. Eur Respir J 2012;40:185-189.